Table 4 Expression of membrane markers in molecular subtypes of ductal breast cancer
From: Immunophenotyping invasive breast cancer: paving the road for molecular imaging
Target | Luminal (242 cases) | HER2-driven (20 cases) | Basal/TN (57 cases) | |||
|---|---|---|---|---|---|---|
N | % | N | % | N | % | |
HER2 | 23 | 9.5 | 20 | 100 | 0 | 0.0 |
EGFR | 25 | 10.3 | 11 | 55 | 35 | 61.4 |
MET | 21 | 8.7 | 4 | 20 | 9 | 15.8 |
IGF1-R | 41 | 16.9 | 2 | 10 | 5 | 8.8 |
GLUT1 | 49 | 20.2 | 6 | 30 | 30 | 52.6 |
CAIX | 11 | 4.5 | 4 | 20 | 23 | 40.4 |
TfR | 33 | 13.6 | 5 | 25 | 40 | 70.2 |
CD44v6 | 148 | 61.8 | 9 | 45 | 15 | 26.3 |
CAXII | 28 | 11.6 | 1 | 5 | 1 | 1.8 |
Mammaglobin | 39 | 16.1 | 4 | 20 | 1 | 1.8 |
MUC1 | 213 | 88.0 | 20 | 100 | 48 | 84.2 |